
Radiation Oncologist at University Hospital Zurich @Unispital_USZ | Professor at University of Zurich @UZH_ch | @ESTRO_RT President
USZ Zurich
Joined February 2018
- Tweets2.3K
- Following271
- Followers5.9K
- Likes5K
🚀 Virtual Grand Round in Radiation Oncology
Latest results of the EXTEND trial
🎤 Dr. Chad Tang
Addition of MTD to SoC for Oligometastatic Solid Tumors: Primary Analysis of EXTEND
📅 2. June 2026, 17:00–17:30 CEST
💻 Join us virtually here: lnkd.in/eiPx5WhQ
Matthias Guckenberger retweeted
🎥 In this #ESTRO26 opening interview, Matthias Guckenberger, President of ESTRO, sets the tone for the days ahead in Stockholm. What does “Innovating Radiation Oncology, Together” really mean in practice? Find out in the video. #radonc @oncoalert @vjoncology @Mat_Guc
❓ What is the optimal duration of ADT if combined with EBRT for definitive treatment of prostate cancer
Virtual Grand Rounds in Radiation Oncology
🎙 Speaker: Dr. @NicholasZaorsky
📅 February 4th, 5 - 5.30 pm CET
💻 Join us virtually here: 👇
usz.ch/en/events/virtual-gra…
Virtual Grand Rounds in Radiation Oncology
🥊 Battle of the Treatment Fields: Advancing Radiation Therapy for Leptomeningeal Metastasis
📅 Today
Dr. Jonathan Yang
5pm - 5:30pm CEST
Please join virtually here
👇
usz.ch/en/event/virtual-gran…
Matthias Guckenberger retweeted
ASTRO is deeply disturbed by the inaccurate, inappropriate, and irresponsible NBC News piece on IORT. We feel this story harms care for breast cancer patients & have strongly rebutted it through our Breast Cancer Resource Panel & a letter from ASTRO CEO, Vivek S Kavadi, MD to NBC News.
Read each here:
Breast Resource Panel Statement
ow.ly/aicz50X9ty1
Letter to NBC News from Dr. Vivek S. Kavadi
ow.ly/Hvy550X9txZ
Matthias Guckenberger retweeted
Important prediction modeling for patients with oligometastatic cancer based on distant metastases velocity (DMV). Great collaboration and proud to contribute our @Sunnybrook data. No doubt that #SBRT is critical to advancing outcomes for these patients. pubmed.ncbi.nlm.nih.gov/4087…
Matthias Guckenberger retweeted
Great collaboration between MOMENTUM and Oligocare registries, presenting the preliminary outcomes (of 15 institutions) regarding liver SBRT using MRI or CT guided approach during #ESTRO2025 !
Matthias Guckenberger retweeted
🎥 Exclusive interview this morning at #ESTRO25:
We spoke with ESTRO President Prof Matthias Guckenberger about the congress highlights, this year’s theme of partnership, and the future of radiation oncology.
Don’t miss his insights ⬇️
#Radiotherapy #CancerResearch @Mat_Guc
Matthias Guckenberger retweeted
Greetings from #ESTRO25 and a wam welcome to #APCCC26 in Lugano 🇨🇭
@Silke_Gillessen @BarbaraJereczek @piet_ost @ZilliThomas @GiulioFrancoli1 @Mat_Guc @VedangMurthy
@OncoAlert 🚨
Matthias Guckenberger retweeted
SBRT + 💊 in oligomets:
🧍♂️2294 pts | 🫁, breast, prostate, colorectal
⚠️Grade 3+ AEs: 1.5%
✅ SBRT Safe with systemic tx!
#SBRT #OligoCare #ESTRO25 @EORTC @ESTRO_RT @CiroFranzese1
Matthias Guckenberger retweeted
Outstanding #ESTRO25 plenary talk from Uffer Pascal, an entrepreneur with stage 4 #lungcancer
“What if radiation oncology was a start up”
Highlights the 5’s:
Collaborate
Communicate
Learn from every Customer
Cost Efficiency
Culture
Matthias Guckenberger retweeted
📢 🚨#lungcancer peeps. Please consider Prof Andrea Bezjak from @UofT for your next IASLC president! A very deserving candidate and a great representative for #radonc!!! @ldawsonmd #lcsm
Matthias Guckenberger retweeted
🎉We’re excited to announce that the first patient has been randomised in the SPRINT study!
The patient was enrolled at Inselspital in Bern, under the supervision of PI Professor Hossein Hemmatazad.
👉 project.eortc.org/e2-radiate…
#E2RADIatE #OligoCare @piet_ost @Mat_Guc
Matthias Guckenberger retweeted
🏅 Interview with Dirk Verellen, recipient of the Emmanuel van der Schueren Award at #ESTRO25: Don’t miss his award lecture in Vienna!
📆 Saturday 3 May | 14:15 - 14:40 CEST | Plenary Hall
👉 Full interview here: bit.ly/4ifJd75
#Radonc #OncologyInnovation #ESTROAwards
SANO trial: non-surgical approach & organ preservation in pts esophageal cancer and complete clinical response after neoadjuvant RCT
Virtual Grand Rounds in Radiation Oncology
usz.ch/en/events/virtual-gra…
Wednesday May 7th 17:00 – 17:30 - Safe the date !
Berend van der Wilk
This Wednesday 👇
❓ Role of SBRT-only in hormone-sensitive oligometastatic prostate cancer
❓ Value of 6-months ADT added to SBRT
❓ Appropriate endpoints
Virtual Grand Rounds in Radiation Oncology
usz.ch/en/events/virtual-gra…
Proudly presenting: @BarbaraJereczek
Wed April 2nd 17:00 – 17:30 CET 👇






























